 | Medical glossary. |
| selected terms: 37 | page 1 of 1 |
- E O9
- (UMLS (NCI) C0059403) =Organic Chemical; Pharmacologic Substance ;;
- EOE
- [This is a rare malignant neoplasm of the soft tissue. It is typically a disease of children and young adults. It is characterized by t(11:22) (q24: q12) resulting in the expression of EWS/FLI-1 chimeric transcript. Most commonly occurs in the paravertebral region, chest wall, pelvis and lower extremities. Treatment includes local excision with consideration for post operative chemotherapy and/or radiotherapy. - 2003 ( NCI )] (UMLS (NCI) C0279980) =Neoplastic Process
- Eon brand of cyclosporine
- [ ] (UMLS (RXNORM) C1165248) =Pharmacologic Substance ;;
- EOP
- (UMLS (NCI) C0280124) =Therapeutic or Preventive Procedure
- Eoquin
- (UMLS (NCI) C1707848) =Organic Chemical; Pharmacologic Substance ;;
- EORTC
- [A group with aims to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life. There are more than 60 institutions and departments that have been recognized by EORTC as affiliated. These groups conduct, on a voluntary basis, laboratory research and/or clinical trials on all types of cancers using a multidisciplinary approach. EORTC maintains close working relationship with NCI and the British Cancer Research United Kingdom in London. ( NCI )] (UMLS (NCI) C1516985) European Organization for Research and Treatment of Cancer;; =Health Care Related Organization ;;
- EOS
- [The determination of the number of eosinophils in a blood sample. ( NCI )] (UMLS (NCI) C0750879) Eosinophil Count;;Eosinophils;; =Laboratory or Test Result ;;
- Eosinophil Precursor Cell
- (UMLS (NCI) C1516898) =Cell
- eosinophilia
- [disordered formation of eosinophils or an abnormal accumulation or deficiency of these cells. ( CSP )] (UMLS (NCI) C0014457) =Disease or Syndrome =Diseases of white blood cells;; =Angiolymphoid Cutaneous Hyperplasia;;eosinophilic granuloma;;EOSINOPHILIA MYALGIA SND;;Hypereosinophilic Syndrome;;
- EOSINOPHILIA MYALGIA SND
- [A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93) ( MSH )] (UMLS (ICD9CM) C0085179) =Disease or Syndrome ;; =eosinophilia;;muscle disorder
- Eosinophilic Brown Fat Cell
- (UMLS (NCI) C1516899) Granular Brown Fat Cell;; =Cell
- Eosinophilic Colitis
- (UMLS (NCI) C0267448) =Disease or Syndrome ;;
- Eosinophilic Endomyocardial Disease
- (UMLS (NCI) C0264834) =Disease or Syndrome ;;
- Eosinophilic Esophagitis
- (UMLS (NCI) C0341106) =Disease or Syndrome
- Eosinophilic Gastritis
- (UMLS (NCI) C0267154) =Disease or Syndrome ;;
- eosinophilic gastroenteritis
- [ ] (UMLS (CSP) C1262481) =Disease or Syndrome
- Eosinophilic Granular Bodies Present
- (UMLS (NCI) C1516900) =Finding
- eosinophilic granuloma
- [most benign clinical form of Langerhans-cell histiocytosis, which involves localized nodular lesions of the gastric mucosa, small intestine, bones, lungs, or skin, with infiltration by eosinophils; the proliferating cell that appears to be responsible for the clinical manifestations is the Langerhans cell. ( CSP )] (UMLS (CSP) C0014461) =Pathologic Function =Bone Diseases;;eosinophilia;;granuloma;;histiocytosis X
- Eosinophilic Infiltrate
- (UMLS (NCI) C1333404) =Finding; ;;
- EOSINOPHILIC MENINGITIS
- [ ] (UMLS (ICD9CM) C0154652) =Disease or Syndrome
- Eosinophilic Meningothelial Cell
- (UMLS (NCI) C1516901) =Cell
- Eosinophilic Pneumonia
- (UMLS (NCI) C1527407) =Disease or Syndrome ;;
- Eosinophilic Variant of Chromophobe Renal Cell Carcinoma
- (UMLS (NCI) C1333405) =Neoplastic Process; ;;
- Eosinophils
- (UMLS (HL7) C1546620) =Intellectual Product =Specimen Source Codes;;
- Eosinophils
- (UMLS (HL7) C1550634) =Body Substance =SpecimenEntityType;;
- Eotaxin
- [A recombinant therapeutic agent which is chemically identical to or similar to the endogenous chemokine eotaxin, a member of the C-C cytokine family which is chemotactic for eosinophils. The early increase in eotaxin paralleled eosinophil infiltration in the asthmatic lung tissue in animal models hinted a potential role for eotaxin in immunotherapy. ( NCI )] (UMLS (NCI) C1527022) Recombinant Eotaxin;; =Amino Acid, Peptide, or Protein; Biologically Active Substance ;;
- EO_Anatomic_Structure_Is_Physical_Part_Of
- [The role is used to associate the anatomical structure of the experimental organism being a part of the larger structure or system. Both the domain and range for this role is EO_Anatomy_Kind. ( NCI )] (UMLS (NCI) C1707850) =Idea or Concept
- EO_Anatomy_Kind
- [Naturally occurring biological structures in non-human organisms. Includes embryological, gross and micro anatomic structures in all species used in research, and as models of human cancer. Excludes proteins and protein complexes smaller than can be visualized by light microscopy. ( NCI )] (UMLS (NCI) C1707851) =Intellectual Product
- EO_Derived_By_Technique
- (UMLS (NCI) C1707852) =Idea or Concept
- EO_Develops_Disease
- (UMLS (NCI) C1707853) =Idea or Concept
- EO_Disease_Has_Associated_Cell_Type
- [The role establishes a relationship between the disease or disorder in the experimental organism and the associated anatomy of the organism. The domain and range for this role are EO_Findings_and_Disorders_Kind and EO_Anatomy_Kind, respectively. ( NCI )] (UMLS (NCI) C1707854) =Idea or Concept
- EO_Disease_Has_Associated_EO_Anatomy
- [The role is used to relate the concept of the disease in the experimental organism to the anatomical site of the experimental organism, where the more specific pathological process is located. The domain is EO_Findings_and_Disorders_Kind and the range is the EO_Anatomy_Kind. ( NCI )] (UMLS (NCI) C1707855) =Idea or Concept
- EO_Disease_Has_Property_Or_Attribute
- [The purpose of this role is to provide semantic relationship between a disease concept in an experimental organism and disease modifiers and qualifiers. The domain for this role is EO_Findings_and_Disorders_Kind and the range is Properties_or_Attributes_Kind. ( NCI )] (UMLS (NCI) C1707856) =Idea or Concept
- EO_Disease_Maps_To_Human_Disease
- [The role is used to establish a relationship between a disease in an experimental organism and a corresponding human disease. The domain and the range for this role is EO_Findings_and_Disorders_Kind and Findings_and_Disorders_Kind, respectively. ( NCI )] (UMLS (NCI) C1711383) =Idea or Concept
- EO_Disease_Metastatic_To_EO_Anatomy
- [The role is used to relate the concept of the disease in experimental organism to the site of a metastatic lesion associated with the disease. The domain of the disease concept is the EO_Findings_and_Disorders_Kind, the range of which is the EO_Anatomy_Kind. ( NCI )] (UMLS (NCI) C1707857) =Idea or Concept
- EO_Findings_and_Disorders_Kind
- [Classification of conditions of non-human organisms that are relevant to cancer. Includes observations, test results, history and other concepts relevant to characterization of cancer-related conditions in species used as models of human cancer. ( NCI )] (UMLS (NCI) C1707858) =Intellectual Product
- EO_Models_Human_Disease
- (UMLS (NCI) C1707859) =Idea or Concept
| UMLS | MEDINDEX.AM |
 to main page | About • Catalog. Medical sites. • UMLS.Semantic Types. • Feedback |  top of page |